0.411 mM [U-15N] HTH-TYPE TRANSCRIPTIONAL REPRESSOR CYTR, 1.14 mM ATTTATGCAACGCA DNA, 50 mM sodium phosphate, 30 mM sodium chloride, 1 mM EDTA, 90% H2O/10% D2O
90% H2O/10% D2O
2
1 mM [U-13C; U-15N] HTH-TYPE TRANSCRIPTIONAL REPRESSOR CYTR, 1.2 mM ATTTATGCAACGCA DNA, 50 mM sodium phosphate, 30 mM sodium chloride, 1 mM EDTA, 90% H2O/10% D2O
90% H2O/10% D2O
3
0.4 mM [U-15N] HTH-TYPE TRANSCRIPTIONAL REPRESSOR CYTR, 0.6 mM ATTTATGCAACGCA DNA, 50 mM sodium phosphate, 30 mM sodium chloride, 1 mM EDTA, 4 % C12E5 PEG/HEXANOL, 90% H2O/10% D2O
NOE constraints total: 556 / NOE intraresidue total count: 233 / NOE long range total count: 41 / NOE medium range total count: 148 / NOE sequential total count: 134 / Protein chi angle constraints total count: 0 / Protein other angle constraints total count: 0 / Protein phi angle constraints total count: 40 / Protein psi angle constraints total count: 37
代表構造
選択基準: minimized average
NMRアンサンブル
コンフォーマー選択の基準: structures with the lowest energy 計算したコンフォーマーの数: 100 / 登録したコンフォーマーの数: 11